Laboratorios Farmaceuticos Rovi (LABFF) News Today C$65.86 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Headlines Stock AnalysisChartShort InterestBuy This Stock LABFF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Increases By 59.8%September 9, 2025 | americanbankingnews.comLaboratorios Farmaceuticos Rovi, S.A. (LABFF) Q2 2025 Earnings Call TranscriptJuly 24, 2025 | seekingalpha.comEuropean Stocks Possibly Trading Below Estimated Value In June 2025June 3, 2025 | finance.yahoo.comLaboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comKepler Capital Sticks to Their Buy Rating for Laboratorios Farmaceuticos Rovi (0ILL)February 8, 2025 | markets.businessinsider.comLaboratorios Farmaceuticos Rovi (0ILL) Gets a Buy from Kepler CapitalJanuary 15, 2025 | markets.businessinsider.com3 Stocks That May Be Priced Below Their Estimated Value In January 2025January 13, 2025 | finance.yahoo.comROVI Corrects English Communication ErrorNovember 8, 2024 | msn.comROVI Retains Control of CDMO Business for GrowthOctober 25, 2024 | msn.comSpanish drugmaker Rovi to keep third-party manufacturing businessOctober 24, 2024 | reuters.comKepler Capital Sticks to Its Buy Rating for Laboratorios Farmaceuticos Rovi (0ILL)September 12, 2024 | markets.businessinsider.comLaboratorios Farmaceuticos Rovi (0ILL) Receives a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comBNP PARIBAS EXANE Downgrades Laboratorios Farmaceuticos Rovi (LABFF)August 12, 2024 | msn.comLaboratorios Farmaceuticos Rovi, S.A. reports 1H resultsAugust 2, 2024 | msn.comRovi (ROVI)July 20, 2024 | es.investing.comLaboratorios Farmaceuticos Rovi, S.A. reports FY resultsFebruary 27, 2024 | msn.comLaboratorios Farmaceuticos Rovi, S.A. (41L.F)February 10, 2024 | finance.yahoo.comLaboratorios Farmaceuticos Rovi S.A. (ROVI)December 14, 2023 | es.investing.comLaboratorios Farmaceuticos Rovi SA ROVINovember 11, 2023 | morningstar.comMLaboratorios Richmond SACIF (RICH)October 13, 2023 | investing.comCAIXABANK BPI Maintains Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Buy RecommendationJune 8, 2023 | msn.comALANTRA EQUITIES Upgrades Laboratorios Farmaceuticos Rovi (XMAD:ROVI)June 8, 2023 | msn.comLaborat.Rovi (ROVI) Earnings Dates & ReportsMay 9, 2023 | investing.comLaboratorios Farmaceuticos Rovi S.A.April 25, 2023 | wsj.comAt Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on BoardApril 11, 2023 | thestreet.comLogista (LOG)April 6, 2023 | es.investing.comLaboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)January 13, 2023 | finance.yahoo.comLaboratorios Farmaceuticos ROVI SANovember 22, 2022 | reuters.com Get Laboratorios Farmaceuticos Rovi News Delivered to You Automatically Sign up to receive the latest news and ratings for LABFF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABFF Media Mentions By Week LABFF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LABFF News Sentiment▼0.980.94▲Average Medical News Sentiment LABFF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LABFF Articles This Week▼00▲LABFF Articles Average Week Get the Latest News and Ratings for LABFF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LABFF) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Laboratorios Farmaceuticos Rovi, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Laboratorios Farmaceuticos Rovi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
